SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025331
Filing Date
2021-05-10
Accepted
2021-05-10 13:30:41
Documents
49
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_aikidopharma.htm 10-Q 252228
2 CERTIFICATION f10q0321ex31-1_aikidopharma.htm EX-31.1 10037
3 CERTIFICATION f10q0321ex32-1_aikidopharma.htm EX-32.1 3980
  Complete submission text file 0001213900-21-025331.txt   2072823

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE aiki-20210331.xml EX-101.INS 230300
5 XBRL SCHEMA FILE aiki-20210331.xsd EX-101.SCH 40531
6 XBRL CALCULATION FILE aiki-20210331_cal.xml EX-101.CAL 23167
7 XBRL DEFINITION FILE aiki-20210331_def.xml EX-101.DEF 150129
8 XBRL LABEL FILE aiki-20210331_lab.xml EX-101.LAB 315058
9 XBRL PRESENTATION FILE aiki-20210331_pre.xml EX-101.PRE 163870
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 21906132
SIC: 8731 Services-Commercial Physical & Biological Research